Generic and Market Intrusion Insights

The introduction of the first generic product or a new brand with a new mechanism of action into a drug category can dramatically disrupt it or may only have a small impact, depending on product costs, which product is losing patent, and the size and stature of the remaining brands.

Generic and Market Intrusion Insights will show you how payers will re-position remaining brands, identify the mechanisms they intend to use to restrict utilization and understand how physicians will respond to these changes.

This report is based on secondary research coupled with primary research with key decision makers at important payer organizations and selected physicians.

Generic and Market Intrusion Insights is specifically geared toward
• Brand marketing
• Market research
• Managed markets marketing

Generic and Market Intrusion Insights for each disease area is published once or twice each year, depending upon market conditions. A typical report consists of:
• Executive summary
• Methodology
• List of participating accounts
• Current and upcoming patent expirations
• Assessment of impact on the category by payer executives
     • Most Likely formulary changes
     • Restrictions on remaining brands
• Assessment of impact by physicians on prescribing
     • Migration of prescription of expiring brand to generic and other brands
     • Intent to deal with restrictions on remaining brands